# OnCo record venetoclax-plus-obinutuzumab (pairing). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/pairings/venetoclax-plus-obinutuzumab/>
  a schema:MedicalTherapy ;
  onco:kind "pairing" ;
  schema:identifier "venetoclax-plus-obinutuzumab" ;
  schema:name "Venetoclax + obinutuzumab (12 months)"@en ;
  schema:description "Venetoclax plus obinutuzumab, one year of a pill plus an antibody, was the first fixed-duration, chemotherapy-free CLL regimen, with half of patients still in remission at six years."@en ;
  schema:url <https://onco.cc/pairings/venetoclax-plus-obinutuzumab/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02242942>, <https://clinicaltrials.gov/study/NCT02950051> ;
  onco:cancers <https://onco.cc/cancers/cll/> ;
  onco:targets <https://onco.cc/targets/bcl2/>, <https://onco.cc/targets/cd20/> ;
  onco:drugs <https://onco.cc/drugs/venetoclax/>, <https://onco.cc/drugs/obinutuzumab/> ;
  onco:trials <https://onco.cc/trials/cll14/>, <https://onco.cc/trials/cll13-gaia/> ;
  onco:pairs <https://onco.cc/drugs/venetoclax/>, <https://onco.cc/drugs/obinutuzumab/> .